Triad of thrombotic phenomena in patients with COVID-19

Descripción del Articulo

COVID-19 disease is associated with a hypercoagulable state with acute inflammatory changes, as well as micro-thrombotic phenomena, favoring the appearance of potentially lethal events, mainly venous thromboembolic events, but also arterial thrombosis, which leads to increased morbidity and mortalit...

Descripción completa

Detalles Bibliográficos
Autores: Durán-Gutiérrez, Luis Fernando, Velasco-Hoyos, María Fernanda, Mileidy- Pastrana Olaya, Karen
Formato: artículo
Fecha de Publicación:2022
Institución:Sociedad Peruana de Medicina Interna
Repositorio:Revista de la Sociedad Peruana de Medicina Interna
Lenguaje:español
OAI Identifier:oai:medicinainterna.net.pe:article/656
Enlace del recurso:https://revistamedicinainterna.net/index.php/spmi/article/view/656
Nivel de acceso:acceso abierto
Materia:Trombosis arterial
tromboembolia venosa
trombosis coronaria
hipercoagulabilidad
COVID-19
SARS-CoV-2.
arterial thrombosis
venous thromboembolism
coronary thrombosis
hypercoagulability
SARS-CoV-2
id REVSPMI_ea04c45814c09b720fb7efa16cdfb4f3
oai_identifier_str oai:medicinainterna.net.pe:article/656
network_acronym_str REVSPMI
network_name_str Revista de la Sociedad Peruana de Medicina Interna
repository_id_str
spelling Triad of thrombotic phenomena in patients with COVID-19Tríada de fenómenos trombóticos en paciente con COVID-19Durán-Gutiérrez, Luis Fernando Velasco-Hoyos, María Fernanda Mileidy- Pastrana Olaya, Karen Trombosis arterialtromboembolia venosatrombosis coronariahipercoagulabilidadCOVID-19SARS-CoV-2.arterial thrombosisvenous thromboembolismcoronary thrombosishypercoagulabilityCOVID-19SARS-CoV-2COVID-19 disease is associated with a hypercoagulable state with acute inflammatory changes, as well as micro-thrombotic phenomena, favoring the appearance of potentially lethal events, mainly venous thromboembolic events, but also arterial thrombosis, which leads to increased morbidity and mortality of patients with SARS-CoV-2 infection. We report the case of a patient who developed a triad of thrombotic phenomena, after an episode of COVID-19 pneumonia.La enfermedad por COVID-19 se asocia con un estado de hipercoagulabilidad condicionado por importantes cambios inflamatorios agudos, además de fenómenos micro trombóticos, que favorecen la aparición de complicaciones potencialmente letales, como tromboembolismo pulmonar (TEP), trombosis venosa profunda (TVP) y trombosis arterial coronaria; que incrementan la morbilidad y mortalidad de los pacientes que cursan con infección por SARS- CoV-2. Reportamos el caso de una paciente que desarrolló una tríada de dichos fenómenos trombóticos, posterior a cuadro de neumonía por COVID-19.Sociedad Peruana de Medicina Interna2022-03-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://revistamedicinainterna.net/index.php/spmi/article/view/65610.36393/spmi.v35i1.656Revista de la Sociedad Peruana de Medicina Interna; Vol. 35 Núm. 1 (2022); 41-44Revista de la Sociedad Peruana de Medicina Interna; Vol. 35 No. 1 (2022); 41-441609-71731681-972110.36393/spmi.v35i1reponame:Revista de la Sociedad Peruana de Medicina Internainstname:Sociedad Peruana de Medicina Internainstacron:SPMIspahttps://revistamedicinainterna.net/index.php/spmi/article/view/656/724https://revistamedicinainterna.net/index.php/spmi/article/view/656/737Derechos de autor 2022 Luis Fernando Durán-Gutiérrez, María Fernanda Velasco-Hoyos, Karen Mileidy- Pastrana Olayainfo:eu-repo/semantics/openAccessoai:medicinainterna.net.pe:article/6562022-04-03T17:45:02Z
dc.title.none.fl_str_mv Triad of thrombotic phenomena in patients with COVID-19
Tríada de fenómenos trombóticos en paciente con COVID-19
title Triad of thrombotic phenomena in patients with COVID-19
spellingShingle Triad of thrombotic phenomena in patients with COVID-19
Durán-Gutiérrez, Luis Fernando
Trombosis arterial
tromboembolia venosa
trombosis coronaria
hipercoagulabilidad
COVID-19
SARS-CoV-2.
arterial thrombosis
venous thromboembolism
coronary thrombosis
hypercoagulability
COVID-19
SARS-CoV-2
title_short Triad of thrombotic phenomena in patients with COVID-19
title_full Triad of thrombotic phenomena in patients with COVID-19
title_fullStr Triad of thrombotic phenomena in patients with COVID-19
title_full_unstemmed Triad of thrombotic phenomena in patients with COVID-19
title_sort Triad of thrombotic phenomena in patients with COVID-19
dc.creator.none.fl_str_mv Durán-Gutiérrez, Luis Fernando
Velasco-Hoyos, María Fernanda
Mileidy- Pastrana Olaya, Karen
author Durán-Gutiérrez, Luis Fernando
author_facet Durán-Gutiérrez, Luis Fernando
Velasco-Hoyos, María Fernanda
Mileidy- Pastrana Olaya, Karen
author_role author
author2 Velasco-Hoyos, María Fernanda
Mileidy- Pastrana Olaya, Karen
author2_role author
author
dc.subject.none.fl_str_mv Trombosis arterial
tromboembolia venosa
trombosis coronaria
hipercoagulabilidad
COVID-19
SARS-CoV-2.
arterial thrombosis
venous thromboembolism
coronary thrombosis
hypercoagulability
COVID-19
SARS-CoV-2
topic Trombosis arterial
tromboembolia venosa
trombosis coronaria
hipercoagulabilidad
COVID-19
SARS-CoV-2.
arterial thrombosis
venous thromboembolism
coronary thrombosis
hypercoagulability
COVID-19
SARS-CoV-2
description COVID-19 disease is associated with a hypercoagulable state with acute inflammatory changes, as well as micro-thrombotic phenomena, favoring the appearance of potentially lethal events, mainly venous thromboembolic events, but also arterial thrombosis, which leads to increased morbidity and mortality of patients with SARS-CoV-2 infection. We report the case of a patient who developed a triad of thrombotic phenomena, after an episode of COVID-19 pneumonia.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistamedicinainterna.net/index.php/spmi/article/view/656
10.36393/spmi.v35i1.656
url https://revistamedicinainterna.net/index.php/spmi/article/view/656
identifier_str_mv 10.36393/spmi.v35i1.656
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistamedicinainterna.net/index.php/spmi/article/view/656/724
https://revistamedicinainterna.net/index.php/spmi/article/view/656/737
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Sociedad Peruana de Medicina Interna
publisher.none.fl_str_mv Sociedad Peruana de Medicina Interna
dc.source.none.fl_str_mv Revista de la Sociedad Peruana de Medicina Interna; Vol. 35 Núm. 1 (2022); 41-44
Revista de la Sociedad Peruana de Medicina Interna; Vol. 35 No. 1 (2022); 41-44
1609-7173
1681-9721
10.36393/spmi.v35i1
reponame:Revista de la Sociedad Peruana de Medicina Interna
instname:Sociedad Peruana de Medicina Interna
instacron:SPMI
instname_str Sociedad Peruana de Medicina Interna
instacron_str SPMI
institution SPMI
reponame_str Revista de la Sociedad Peruana de Medicina Interna
collection Revista de la Sociedad Peruana de Medicina Interna
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846973726722097152
score 12.834301
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).